palivizumab

You have access
Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection
COMMITTEE ON INFECTIOUS DISEASES and BRONCHIOLITIS GUIDELINES COMMITTEE

Pediatrics, Aug 2014, 134 (2) e620-e638

PDF
You have access
Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection
COMMITTEE ON INFECTIOUS DISEASES AND BRONCHIOLITIS GUIDELINES COMMITTEE

Pediatrics, Aug 2014, 134 (2) 415-420

PDF
You have access
Respiratory Syncytial Virus Prophylaxis in Down Syndrome: A Prospective Cohort Study
Hao Yi, Krista L. Lanctôt, Louis Bont, Beatrijs L.P. Bloemers, Michel Weijerman, Chantal Broers, Abby Li, Alexander Kiss, Ian Mitchell, Bosco Paes on behalf of the CARESS investigators

Pediatrics, Jun 2014, 133 (6) 1031-1037

PDF
You have access
RSV Immunoprophylaxis: Does the Benefit Justify the Cost?
H. Cody Meissner, David W. Kimberlin

Pediatrics, Nov 2013, 132 (5) 915-918

PDF
You have access
Admission to the Intensive Care Unit for Respiratory Syncytial Virus Bronchiolitis: A National Survey Before Palivizumab Use
Dario Prais, Tommy Schonfeld, Jacob Amir for the Israeli RSV Monitoring Group

Pediatrics, Sep 2003, 112 (3) 548-552

PDF